Yuankai Shi

1PUBLICATIONS
3CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Feb 18, 2020
Effect of anlotinib as a third- or further-line therapy in advanced non-small cell lung cancer patients with different histologic types: Subgroup analysis in the ALTER0303 trial.

Ying Cheng, Baohui Han, Kai Li

Pageof 1

Frequent Collaborators

1 joint publications

Ying Cheng

1 joint publications

Baohui Han

1 joint publications

Kai Li